China News Service, September 2 According to Singapore’s "Lianhe Zaobao" report, on September 1, local time, a newly released study showed that more than 90% of COVID-19 patients in Iceland maintain a stable level of antibody levels after rising. It can last for four months.
August 11, 2020, local time, Moscow, Russia, Binnopharm's new crown vaccine production laboratory.
Image source: People's Vision
According to reports, in previous related studies, the level of antibodies in survivors of the new crown has dropped rapidly, which has raised questions about the long-term effectiveness of immune antibodies in survivors of new crown.
According to the report, the report was issued by the “deCode Genetics” organization. The purpose of the research is to understand how many people in the Icelandic population are infected with the new crown and the immune level of the new crown survivors. Researchers have tested more than 30,000 Icelanders. Antibody levels.
Based on the results, they estimate that about 1% of the Icelandic population has been infected with the new crown. Among the infected, 56% have been tested for the virus and confirmed the infection; the other 14% have not been formally diagnosed before, but have been isolated because of contact with the infected person; the remaining 30% of people passed the antibody test and found out that they had been infected with the new crown before.
The researchers said that 91% of the 1,215 people who were confirmed to be infected by the virus test had an increase in antibody levels in the first two months and remained stable after two months.
"Decoding Genetics" CEO Stefanson said that this new discovery may have implications for understanding the risk of survivors being infected again with the new crown and the effectiveness of the vaccine.
Prior to this, secondary infections have been detected in the United States, the Netherlands, Belgium, and Ecuador.